alcohol and glp 1 GLP-1 medications: The next big thing in use disorder treatment? – Recovery Research Institute GLP-1s Hold Promise as Treatment

Glucagon-mediated enhancement in insulin secretion, independent of GcgR-mediated glucose production, has been suggested to occur via paracrine activation of the -cell GLP-1 receptor in the post-prandial state [174], [2], [25]

There were about 589 million adults around the world living with diabetes in 2024, with 90% having type 2 diabetes

Beneficial Consequences of GLP-1RA Effects on Gastric Emptying Reduction in Postmeal Glycemic Excursions Elevation of postprandial glycemia (PPG) is characteristically the initial defect in glucose intolerance (1) and is a challenging aspect of the management of T2D (2)

Time is cumulative

"Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss"

JAMA 2022;327:534-45.ArticlePubMedPMC 129